Novo Nordisk has signed a deal worth up to $1bn with Lexicon Pharmaceuticals for the exclusive global rights to oral therapy ...

With the changes, manufacturers will be allowed to increase the maximum retail price (MRP) of scheduled formulations on the ...

The new recipients of 23andMe’s data would not necessarily have to offer consumers the ability to opt out once they take possession of it. And it remains unclear which (or how many) hands the data ...

The United States led the world in developing the technology that beat the COVID-19 pandemic. Action from lawmakers may leave ...

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02. A ...

Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...

Chinese President Xi Jinping meets with representatives of the international business community at the Great Hall of the ...

Essential medicines for managing conditions like diabetes, cancer, heart disease, and bacterial infections such as painkillers, antibiotics, anti-infectives, anti-diabetics and cancer drugs are set to ...

Value stocks aren't typically the most exciting investments, but they can often provide steady capital gains without causing investors to lose any sleep during periods of market volatility.

April 2 marks a crucial day as U.S. President Trump plans to announce reciprocal tariffs, escalating the trade war. This move ...

In response, Rocket Lab stock soared by more than 7% in the opening minutes of trading Friday before retreating to about a ...